The global Rx medical food market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to fuel the global Rx medical food market during the forecast period includes increasing regulatory support and awareness about medical food among healthcare professionals. Moreover, the other factors that will augment the market growth include major investments by key players such as Nestlé and Danone in the R&D of medical foods, along with a widening scope across applications such as chronic pain, and personalized medicine. Rx medical food currently available in the market includes Axona (Accera), Limbrel, Deplin, Lofenalac, Ensure, Vasculera, and Vascazen. Medical food is a category of food products for dietary management or preventive therapy for a specific disease or medical conditions such as pulmonary, gastrointestinal, and metabolic disorders. Ingredients used in medical foods must have generally recognized as safe (GRAS) status. Medical food is different from nutritional food, dietary supplements, as well as from prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and isoflavones), and may contain minerals and vitamins such as folic acid and thiamine.
To Request a Sample of our Report on Global Rx Medical Food Market: https://www.omrglobal.com/request-sample/rx-medical-food-market
These products are prescribed by physicians or taken under their supervision. Medical foods are classified by the US Food & Drug Administration (FDA), into four major categories; nutritionally complete products, nutritionally incomplete products, formulas for metabolic disorders, and oral rehydration solutions. The US FDA separately regulates medical food under Orphan Drug Act (1988) to ensure the safety of the populace and curb the presence of products falsely claiming to cure medical conditions. Medical food does not require premarket approval, specification as an investigational new drug (IND), and individual registration with the FDA. However, they are required to support all their health claims with proper laboratory and clinical studies. The major factors that are restraining the growth of the global Rx medical food market include side effects and complications caused by Rx medical food products if they are consumed in excess amounts.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: Abbott Laboratories, Danone S.A., and Nestlé S.A., among others.
(Get 15% Discount on Buying this Report)
A full Report of Global Rx Medical Food Market is Available at: https://www.omrglobal.com/industry-reports/rx-medical-food-market
Global Rx Medical Food Market Report by Segment
By Type
• Pills
• Powder
• Liquid
• Others
By Application
• Pain Management
• Neurological Disorder
• GI Disorder
• Pulmonary Disorders
• Metabolic Disorders
• Others
Global Rx Medical Food Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
